12 Course Descriptions
In accordance with Senate's Policy Regarding Inactive Courses, the course descriptions for courses which have not been offered in the previous three Academic years and which are not scheduled to be offered in the current Academic year have been removed from the following listing. For information about any of these inactive courses, please contact the Dean of the School.
A student is advised to pay attention to Usage Limitation (UL) for each course to determine its program applicability.
All courses of the School are designated by PHAR and are restricted to students in the School of Pharmacy.
PHAR 2002 Anatomy and Physiology I
provides an overview of human anatomy and physiology throughout the lifespan. It includes aspects of cytology and histology that form a foundation for the practice of pharmacy. The focus will be on developing an understanding of the interrelationships and integration of all systems from the cell to whole organism. Special emphasis is given to the skeletal, muscular, nervous, and endocrine systems.
PHAR 2003 Anatomy and Physiology II
provides an overview of human anatomy and physiology throughout the lifespan. It includes aspects of cytology and histology that form a foundation for the practice of pharmacy. The focus will be on developing an understanding of the interrelationships and integration of all systems from cell to whole organism. Special emphasis is given to the circulatory, respiratory, urinary, digestive, and reproductive systems.
PHAR 2004 Introduction to Biochemistry
is an introduction to the major organic substances of living organisms, proteins, carbohydrates and lipids: their structure, analysis and biochemical function. Other topics include: enzymes; the biochemistry of membranes, including the plasma membrane and specialized intracellular membranes; and the biochemistry of selected differentiated cells.
Human Biosciences 2001 or the former Biochemistry 2101 or 2201
PHAR 2010 Service Learning
requires completion of 20 hours of service in the community in any term within the first year of the program. Students will engage in projects or activities which will benefit both the host organization and the student. It will occur in an approved setting either in the academic community or with an off-campus community group. The goal is to provide opportunities for the student to develop communication and self-reflective learning skills, acquire new frames of reference and perspectives, and gain an enhanced sense of civic responsibility.
PHAR 2201 Pharmaceutics I
provides an insight into a number of physicochemical basics and explains them within a pharmaceutical context. The course provides the basic foundation necessary for the study of pharmaceutical dosage forms, pharmacokinetics and bio-pharmaceutics.
attendance is required in laboratory sessions
3
PHAR 2202 Pharmaceutics II
is designed to provide the student with an understanding of pharmaceutical dosage forms and their applications. It applies the principles taught in Pharmaceutics I to understand the design and components of the different pharmaceutical preparations.
attendance is required in laboratory sessions
3
PHAR 2250 Pharmacy Practice I
begins the acquisition and application of the knowledge the knowledge, skills, and attitudes necessary for pharmacy practice. The course will include an introduction to calculations, technical skills and the legal and regulatory framework of pharmacy practice. Application will occur in simulated pharmacy practice situations. Students must demonstrate skill proficiency in patient care, drug information, communication, professionalism, critical thinking, and teamwork at a level appropriate for the year of study in order to pass the course.
PHAR 2251 Pharmacy Practice II
continues the acquisition, development, and application of the knowledge, skills, and attitudes necessary for pharmacy practice. The legal and professional framework of pharmacy practice, patient counselling, and technical skills will be emphasized. Application will take place in real and simulated pharmacy practice situations. Students must demonstrate skill proficiency in patient care, drug information, communication, professionalism, critical thinking and teamwork at a level appropriate for the year of study to in order to pass the course.
PHAR 2610 Health Systems
provides an introduction to the Canadian healthcare system, its development, history, structure, and financing. The federal and provincial governments’ involvement in the healthcare system and health policy will be presented. The roles and responsibilities of the pharmacist within healthcare will also be examined.
PHAR 2620 Social and Ethical Behaviours
introduces the social and cultural factors and determinants that influence health in Canada, and their ethical implications. Theoretical approaches from a social perspective, including value systems in Canada, ethical dilemmas and the role of ethics in pharmacy practice will be discussed.
PHAR 3006 Immunology
is an introduction to the cells and organs of the innate and adaptive immune systems. The molecular and cellular basis of allergy, autoimmunity, vaccination and cancer immunology will also be discussed.
PHAR 305P Pharmacy Practice Experience I
provides six weeks (240 hours) of practice experience in a community pharmacy. The focus will be on the legal and regulatory framework governing pharmacy practice, prescription processing, gathering and assessing patient information, patient education, drug information, health promotion, and quality assurance. Students will apply their knowledge and skills in the provision of patient care. Effective communication skills, professionalism, and teamwork are expected.
PHAR 3111 General Biochemistry
covers the catabolism of carbohydrates, lipids and amino acids. Mitochondria, chloroplasts and ATP synthesis. Biosynthesis of carbohydrates and lipids. Metabolic specialization of differentiated cells and tissues. Integration of metabolism.
Human Biosciences 2003 or the former Biochemistry 3106 or 3206
PHAR 3250 Pharmacy Practice III
continues the acquisition, development, and application of the knowledge, skills, and attitudes necessary for pharmacy practice. The focus will include patient assessment, care plan development, counselling, follow-up, interprofessional collaboration, and communication with special patient populations. Application will occur in real and simulated pharmacy practice situations. Students must demonstrate skill proficiency in patient care, drug information, communication, professionalism, critical thinking, and teamwork at a level appropriate for the year of study to pass the course.
PHAR 3251 Pharmacy Practice IV
continues the acquisition, development, and application of the knowledge, skills, and attitudes necessary for pharmacy practice. This course will build on pharmacy practice concepts and will emphasize patient safety. Application will take place in simulated pharmacy practice situations. Students must demonstrate skill proficiency in patient care, drug information, communication, professionalism, critical thinking, and teamwork at a level appropriate for the year of study in order to pass the course.
PHAR 3270 Pharmacotherapy I
introduces pharmacotherapeutic management of common diseases and effective management of patients’ drug therapy. Emphasis will be placed on identifying drug therapy problems, establishing therapeutic outcomes, recommending pharmacological and non-pharmacological therapeutic alternatives, developing individualized therapeutic regimens, and developing a monitoring plan to evaluate adherence, efficacy, and safety. Topics may include drug interactions, gastroenterological conditions, musculoskeletal conditions, nutrition, and special populations.
PHAR 3271 Pharmacotherapy II
continues the discussion of pharmacotherapeutic management of common diseases and effective management of patients’ drug therapy. Emphasis will be placed on identifying drug therapy problems, establishing therapeutic outcomes, recommending pharmacological and non-pharmacological therapeutic alternatives, developing individualized therapeutic regimens, and developing a monitoring plan to evaluate adherence, efficacy, and safety. Topics may include cardiovascular, dermatological, respiratory, and infectious diseases.
PHAR 3410 Leadership and Health Promotion
focuses on the roles of leadership, advocacy, and health promotion in pharmacy to improve patient care. Insight into leadership skills and the roles of educating, advocating, and promoting health to patients, families, communities, and society will be discussed. The change process and the leader’s role in change will be introduced.
PHAR 3801 Pathophysiology I
examines the nature of disease, causes and effects, and alterations in structure and function of cells. Topics may include cardiovascular, dermatological, gastrointestinal, and respiratory diseases.
PHAR 3805 Pharmacology I
provides an introduction to the general principles of pharmacology including dose-response relationships, drug-receptor interactions, absorption, distribution, metabolism, and elimination of drugs. The focus will be on the pharmacological basis of the action of drugs leading to therapeutic effects, as well as adverse effects. Topics may include drugs used in the management of cardiovascular, gastrointestinal, respiratory diseases, and anti-inflammatory drugs.
PHAR 3810 Microbiology of Infectious Diseases
examines the various types of micro-organisms (bacterial, viral, parasitic, and fungal), microbial growth, and their relationship to human diseases. The classifications of their morphology, mode of reproduction, and the metabolic process will be discussed.
PHAR 3825 Medicinal Chemistry
examines the functional group recognition and properties of drugs, drug-receptor interactions, structure activity relationships, and rational drug design. The relationship between the chemical structure of a drug and its binding affinity toward intended target enzymes or receptors, and its pharmacological activity, will be discussed.
PHAR 406P Pharmacy Practice Experience II
provides two weeks (80 hours) of practice experience in a hospital pharmacy practice setting. The focus will be on the operations of a hospital pharmacy, including drug distribution, policies and procedures, and communicating with other healthcare professionals. Students will apply their knowledge and skills in the provision of pharmacy services. Effective communication skills, professionalism, and teamwork are expected.
PHAR 407P Pharmacy Practice Experience III
provides four weeks (160 hours) of practice experience in a direct patient care setting. Emphasis will be on continuing to develop patient care skills by working with a variety of patients and the healthcare team to appropriately identify, prevent, and resolve drug-related problems. Effective communication skills, professionalism, and teamwork, are expected.
PHAR 4250 Pharmacy Practice V
continues the acquisition, development, and application of the knowledge, skills, and attitudes necessary for pharmacy practice. Critical appraisal, patient safety, and interprofessional collaboration will be emphasized. Application take place in simulated pharmacy practice situations. Students must demonstrate skill proficiency in patient care, drug information, communication, professionalism, critical thinking, and teamwork at a level appropriate for the year of study in order to pass the course.
PHAR 4251 Pharmacy Practice VI
continues the acquisition, development, and application of the knowledge, skills, and attitudes necessary for pharmacy practice. Sterile product preparation, drug information, patient safety, and calculations relevant to hospital practice will be introduced. Critical appraisal and interprofessional collaboration will continue. Application will take place in simulated pharmacy practice situations. Students must demonstrate skill proficiency in patient care, communication, professionalism, critical thinking, and teamwork at a level appropriate for the year of study to pass the course.
PHAR 4270 Pharmacotherapy III
continues the discussion of pharmacotherapeutic management of common diseases and effective management of the patient’s drug therapy. Emphasis will be placed on identifying drug therapy problems, establishing therapeutic outcomes, recommending pharmacological and non-pharmacological therapeutic alternatives, developing individualized therapeutic regimens, and developing a monitoring plan to evaluate adherence, efficacy, and safety. Topics may include autoimmune, infectious, and musculoskeletal diseases.
PHAR 4271 Pharmacotherapy IV
continues the discussion of pharmacotherapeutic management of common diseases and effective management of patients’ drug therapy. Emphasis will be placed on identifying drug therapy problems, establishing therapeutic outcomes, recommending pharmacological and non-pharmacological therapeutic alternatives, developing individualized therapeutic regimens, and developing a monitoring plan to evaluate adherence, efficacy, and safety. Topics may include cardiovascular, endocrine and renal disease, and women’s and men’s health.
PHAR 4420 Pharmacy Management I
introduces the principles of management and leadership as they relate to pharmacy practice. Topics will include the pharmacy practice environment, human resources management, financial management, operations management, marketing, risk management, quality control and improvement, and effective communications.
PHAR 4621 Applied Health Research I
introduces the fundamentals of statistical methods and biostatistics, and other topics relevant to conducting and analyzing medical research.
PHAR 4622 Applied Health Research II
introduces the fundamentals of research design, methods, and appraisal necessary to develop the skills to analyze and interpret clinical research. Topics include randomized clinical trials, observational studies, and pharmacoeconomic evaluations. Emphasis will be placed on making valid inferences about drug safety and effectiveness from scientific research. Principles of critically appraising the medical literature will be introduced.
PHAR 4802 Pathophysiology II
examines the nature of disease, causes and effects, and alterations in structure and function of cells. Topics may include endocrine disorders, renal, rheumatological and neurological diseases, neoplasia, and women’s and men’s health.
PHAR 4810 Pharmacology II
will focus on the pharmacological basis of the action of drugs leading to therapeutic effects, as well as adverse effects. Topics may include drugs used in the management of infectious diseases, the endocrine system, and inflammatory diseases, as well as hormonal drugs and analgesics.
PHAR 4820 Pharmacokinetics
is an introduction to the biopharmaceutical and pharmacokinetic principles used in the selection, dosing, and monitoring of drug therapy. The concepts of absorption, distribution, metabolism and elimination, pharmacokinetic and pharmacodynamics mechanisms of drug interactions, and the importance of drug monitoring will be explored.
PHAR 4860 Pharmacogenomics and Biotechnology
provides insight into the development of biopharmaceuticals. Formulation, stability, dispensing, and clinical applications of biotechnology derived protein/peptide drugs will be discussed. The fundamental concepts of pharmacogenetics and pharmacogenomics will be explored. A focus will be on understanding how personalized drug therapy, based on the genetic profile of individuals, can optimize drug therapy and patient care.
PHAR 4900 Clinical Skills I
is an on-campus, three-day (21 hours) orientation to the fundamental knowledge and skills for advanced practice. Topics such as informatics, communication, and patient assessment may be explored. This course may commence outside the semester start and end dates.
PHAR 4901 Essentials of Pharmacy Practice
provides the foundational principles and skills of pharmacy practice such as the provision of patient-centred care, pharmacokinetics, and social justice. The pass grade is 60%.
PHAR 4902 Pharmacy Management and Leadership
explores the principles of change management and leadership as they relate to pharmacy practice. Topics may include the business environment, financial management, continuous quality improvement, business marketing and promotion, human resources management, pharmacy services implementation, effective pharmacy operations, and technology in pharmacy practice. The pass grade is 60%.
PHAR 4903 Evidence-Based Practice
integrates advanced drug information and critical evaluation of the medical literature. Students will apply their knowledge of pharmacy practice research and evidence-based practice to inform therapeutic decision-making. The pass grade is 60%.
PHAR 4910 Applied Learning I
focuses on the application of leadership skills to implement change in practice through education and advocacy. Students will demonstrate their learning through the completion of applied learning activities at their practice sites. When numeric grading is used, the pass grade is 60%.
PHAR 5250 Pharmacy Practice VII
continues the acquisition, development, and application of the knowledge, skills, and attitudes necessary for pharmacy practice. Critical appraisal, patient safety, and interprofessional collaboration will be emphasized. Students will be expected to demonstrate increased independence during the application of knowledge and skills in simulated pharmacy practice situations. Students must demonstrate skill proficiency in patient care, communication, professionalism, critical thinking, and teamwork at a level appropriate for the year of study in order to pass the course.
PHAR 5251 Pharmacy Practice VIII
is the final course in the series where students acquire, develop, and apply the knowledge, skills, and attitudes necessary for pharmacy practice. Application of knowledge and skills will occur in simulated pharmacy practice situations. Students must demonstrate skill proficiency in patient care, drug information, communication, professionalism, critical thinking, and teamwork at a level appropriate for the year of study in order to pass the course.
PHAR 5270 Pharmacotherapy V
is the final course in the series that examines the pharmacotherapeutic management of common diseases and effective management of the patient’s drug therapy. Emphasis will be placed on identifying drug therapy problems, establishing therapeutic outcomes, recommending pharmacological and non-pharmacological therapeutic alternatives, developing individualized therapeutic regimens, and developing a monitoring plan to evaluate adherence, efficacy, and safety. Topics may include neurological, oncological, and addictions and mental health conditions.
PHAR 5271 Advanced Pharmacotherapy
expands and integrates the knowledge and skills acquired from the Pharmacotherapy series of courses through application to complex patient scenarios. Critical thinking skills necessary for optimizing pharmacotherapy in a variety of patient care situations will be the focus of the course.
PHAR 5275 Symposium in Pharmacy
is a forum for students to research, develop and deliver formal presentations related to pharmacy practice. Students will be expected to interpret, synthesize, and present information effectively. The presentations will allow for application of knowledge and reflection on content.
PHAR 5430 Pharmacy Management II
prepares students for the various roles of management in pharmacy practice, regardless of position or practice setting. Management principles including communications, leadership, finance, human resources management, marketing, and promotion will be applied through demonstrating leadership, business planning, and pharmacy service implementation.
PHAR 5640 Social Justice and the Pharmacist
will enable students to critically analyse the role of social justice as an integral part of the practice of pharmacy. The course will include a focus on the interconnectedness of health equity with global contexts that include social class, ethnicity, gender, ability, and mental health. Critical thinking skills will be used to examine complex health and social issues.
PHAR 5815 Pharmacology III
is the final course in the series that focuses on the pharmacological basis of the action of drugs leading to therapeutic effects, as well as adverse effects. Topics may include drugs used in the management of oncological, mental health, and neurological conditions as well as drugs of abuse.
PHAR 5830 Applied Pharmacokinetics
discusses pharmacokinetic principles of drug selection, dosing, and monitoring in the clinical setting for individualization of drug therapy.
PHAR 5901 Pharmaceutical Care I
integrates the knowledge and skills necessary for the effective management of medication therapy in the provision of patient-centred care. Students will apply their knowledge of patient assessment, pharmacotherapy, and evidence-based practice to evaluate therapeutic options primarily for diseases of the cardiovascular system. The pass grade is 60%.
PHAR 5902 Pharmaceutical Care II
integrates the knowledge and skills necessary for the effective management of medication therapy in the provision of patient-centred care. Students will apply their knowledge of patient assessment, pharmacotherapy, and evidence-based practice to evaluate therapeutic options primarily for renal, digestive, and oncological diseases. The pass grade is 60%.
PHAR 5903 Pharmaceutical Care III
integrates the knowledge and skills necessary for the effective management of medication therapy in the provision of patient-centred care. Students will apply their knowledge of patient assessment, pharmacotherapy, and evidence-based practice to evaluate therapeutic options primarily for diseases of the protective, structural, and endocrine systems. The pass grade is 60%.
PHAR 5904 Pharmaceutical Care IV
integrates the knowledge and skills necessary for the effective management of medication therapy in the provision of patient-centred care. Students will apply their knowledge of patient assessment, pharmacotherapy, and evidence-based practice to evaluate therapeutic options primarily for respiratory and infectious diseases. The pass grade is 60%.
PHAR 5905 Pharmaceutical Care V
integrates the knowledge and skills necessary for the effective management of medication therapy in the provision of patient-centred care. Students will apply their knowledge of patient assessment, pharmacotherapy, and evidence-based practice to evaluate therapeutic options primarily for neurological disorders and mental health conditions. The pass grade is 60%.
PHAR 5920 Applied Learning II
focuses on the principles of medication safety, medication use evaluation, adverse drug events, and medication errors and incident reporting. Students will demonstrate their learning through the completion of applied learning activities at their practice sites. When numeric grading is used, the pass grade is 60%.
PHAR 605P Advanced Pharmacy Practice Experience: Direct Patient Care
is an eight week (320 hours) practice experience completed during the final year of the program (following Academic Term 11). Students will be expected to demonstrate leadership in the responsible provision of patient care by becoming an integral member of the healthcare team while confidently using clinical reasoning and critical thinking skills. Mentorship of junior students may be a component of this experience. Advanced Pharmacy Practice Experiences (APPE) may occur at any time during the academic year and may be offered in whole or in part outside the normal start and end dates of a semester.
PHAR 606P Advanced Pharmacy Practice Experience: Acute Care Hospital
is an eight week (320 hours) practice experience where patient care is provided in an acute care hospital setting and is completed during the final year of the program (following Academic Term 11). Students will be expected to demonstrate leadership in the responsible provision of patient care by becoming an integral member of the healthcare team while confidently using clinical reasoning and critical thinking skills. Mentorship of junior students may be a component of this experience. Advanced Pharmacy Practice Experiences (APPE) may occur at any time during the academic year and may be offered in whole or in part outside the normal start and end dates of a semester.
PHAR 607P Advanced Pharmacy Practice Experience: Community Pharmacy
is an eight week (320 hours) practice experience where patient care is provided in a community pharmacy setting and is completed during the final year of the program (following Academic Term 11). Students will be expected to demonstrate leadership in the responsible provision of patient care by applying expanded scope of practice skills, as well as communicating and collaborating with patients, the pharmacy team, other health professionals, and the public while confidently using clinical reasoning and critical thinking skills. Mentorship of junior students may be a component of this experience. Advanced Pharmacy Practice Experiences (APPE) may occur at any time during the academic year and may be offered in whole or in part outside the normal start and end dates of a semester.
PHAR 608P Advanced Pharmacy Practice Experience: Selective
is an eight week (320 hours) experience completed during the final year of the program (following Academic Term 11). The experience may occur in either a direct or non-direct patient care setting. Options include patient care, research, health policy, drug information, teaching/education, advocacy, and administration. Placements may vary from year to year depending upon site and preceptor availability. Advanced Pharmacy Practice Experiences (APPE) may occur at any time during the academic year and may be offered in whole or in part outside the normal start and end dates of a semester.
attendance is required
10
all Academic Term 10 & 11 courses
PHAR 610P Advanced Pharmacy Practice Experience: Direct Patient Care I
is a six week (240 hours) practice experience completed during the final year of the program. Students will develop their medication therapy management skills and pharmaceutical care in an ambulatory care setting. Students will be expected to demonstrate leadership in the responsible provision of patient care by becoming an integral member of the healthcare team while confidently using clinical reasoning and critical thinking skills. Mentorship of junior students may be a component of this experience. Advanced Pharmacy Practice Experiences (APPE) may occur at any time during the academic year and may be offered in whole or in part outside the normal start and end dates of a semester.
attendance is required
9
applicable only to the Doctor of Pharmacy for Working Professionals
PHAR 611P Advanced Pharmacy Practice Experience: Direct Patient Care II
is a six week (240 hours) practice experience completed during the final year of the program. Students will develop the essential skills necessary to provide direct patient care to patients with complex pharmacotherapy needs, such as an inpatient hospital unit, acute care ambulatory care clinic, or a long-term care facility. Students will be expected to demonstrate leadership in the responsible provision of patient care by becoming an integral member of the healthcare team while confidently using clinical reasoning and critical thinking skills. Mentorship of junior students may be a component of this experience. Advanced Pharmacy Practice Experiences (APPE) may occur at any time during the academic year and may be offered in whole or in part outside the normal start and end dates of a semester.
attendance is required
9
applicable only to the Doctor of Pharmacy for Working Professionals
PHAR 6900 Clinical Skills II
is an on-campus, three-day (21 hours) introduction to the Advanced Pharmacy Practice Experience component of the program. The focus will be on topics that enable students to practice to their full scope. Students will continue to demonstrate skills in communication, patient assessment, and documentation. This course may commence outside the semester start and end dates.
PHAR 6930 Applied Learning III
focuses on the expansion of skills in patient assessment, communication, documentation, and interprofessional collaboration through the provision of patient-centred care. Students will demonstrate their learning through the completion of applied learning activities. When numeric grading is used, the pass grade is 60%.
PHAR 6900
applicable only to the Doctor of Pharmacy for Working Professionals
AN = Additional notes. AR = Attendance requirement as noted. CH = Credit hours: unless otherwise noted, a course normally has a credit value of 3 credit hours. CO = Co-requisite(s): course(s) listed must be taken concurrently with or successfully completed prior to the course being described. CR = Credit restricted: The course being described and the course(s) listed are closely related but not equivalent. Credit is limited to one of these courses. Normally, these courses cannot be substituted, one for the other, to satisfy program requirements. EQ = Equivalent: the course being described and the course(s) listed are equal for credit determination. Credit is limited to one of these courses. These courses can be substituted, one for the other, to satisfy program requirements. |
LC = Lecture hours per week: lecture hours are 3 per week unless otherwise noted. LH = Laboratory hours per week. OR = Other requirements of the course such as tutorials, practical sessions, or seminars. PR = Prerequisite(s): course(s) listed must be successfully completed prior to commencing the course being described. UL = Usage limitation(s) as noted. |
Copyright © 2024 Memorial University of Newfoundland.
Newfoundland and Labrador, Canada.
calendar.editor@mun.ca